Hanmi signs record $2.3b obesity drug deal with Genentech
--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-08-24 15:27 UTC+10:00
Section: All News
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Elections, Drugs, World News
--------------------------------------------------------------------
Snippet:
Hanmi Pharmaceutical said Monday it has inked an exclusive licensing agreement with Genentech for its obesity drug candidate HM17321 in a deal that could be worth up to $2.3 billion, setting new record for the firm for a licensing contract of a single drug candidate.
--------------------------------------------------------------------